Infection Prevention and Control Practices Regarding COVID-19 (IPCP)

November 19, 2021 updated by: Ayat Zammar, King Saud University

Infection Prevention and Control Practices Among Primary Healthcare Nurses Regarding COVID-19 in Saudi Arabia

Background: Healthcare providers, particularly nurses, are at risk of infection as part of the COVID-19 epidemic chain since they assist in the disease's containment. By recognising the risk factors for infection and implementing suitable measures to reduce these risks, all reasonable efforts should be taken to control the spread of infection to them. The major aim of the present study was to determine the level of infection prevention and control practises used by primary healthcare nurses in Saudi Arabia during the COVID-19 pandemic.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

198

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Riyadh, Saudi Arabia, 11451
        • King Saud university

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

healthcare practitioners and community health nurses who worked at the aforementioned centres. There are 800 nurses in total.

Description

Inclusion Criteria:

  • Male and female healthcare practitioners with at least one year of experience and who worked in all areas of primary healthcare facilities during the COVID-19 epidemic.

Exclusion Criteria:

  • Healthcare providers that are unwilling to participate in the present study have been eliminated

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Primary Healthcare Nurses
Nurses allocated in primary Healthcare settings
The questionnaire's first section asked for demographic information such as gender, age, the name of the primary healthcare centre, and level of education. The second section comprised sources of knowledge on COVID-19; respondents replied on a scale of 1 least used (1), occasionally (2), more frequently (3), and most used (4). The third section had six items pertaining to nurses' infection prevention and control methods with reference to COVID-19, and respondents replied on a scale of yes (2), occasionally (1), and no (0). Permission to use the questionnaire has been requested from the author and is awaited.
Non Nurses Primary Healthcare
Other Healthcare providers allocated in primary health care settings
The questionnaire's first section asked for demographic information such as gender, age, the name of the primary healthcare centre, and level of education. The second section comprised sources of knowledge on COVID-19; respondents replied on a scale of 1 least used (1), occasionally (2), more frequently (3), and most used (4). The third section had six items pertaining to nurses' infection prevention and control methods with reference to COVID-19, and respondents replied on a scale of yes (2), occasionally (1), and no (0). Permission to use the questionnaire has been requested from the author and is awaited.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Distribution of study participants by gender, age group, marital status, and income level in a self-reported questionnaire.
Time Frame: Once within 6 weeks
Demographic data included age, gender, experience, educational level, marital status, income and job will be assessed using numerical code for each demographic variable.
Once within 6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Detection of source of knowledge regarding COVID-19 prevention methods
Time Frame: Once within 6 weeks
Using self-reporting questionnaire, will assess Social Media, Radio & television, Seminars & workshops, Posters & Pamphlets, Newspapers &Magazines and Seniors & Other Colleagues from (Least used= 1 to Most used= 4).
Once within 6 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Circumstances when Healthcare providers practice infection prevention tasks in settings.
Time Frame: Once within 6 weeks
Assess the use of Personl Protective Equipments (Gloves, Mask(regular), N95 respirator mask, Surgical mask, Goggles, Apron, Gown, Isolation gown, Hair cover, Shoe cover and Eye protection) from Never(0) to Always (4).
Once within 6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 12, 2020

Primary Completion (Actual)

September 15, 2021

Study Completion (Actual)

September 15, 2021

Study Registration Dates

First Submitted

November 16, 2021

First Submitted That Met QC Criteria

November 19, 2021

First Posted (Actual)

November 23, 2021

Study Record Updates

Last Update Posted (Actual)

November 23, 2021

Last Update Submitted That Met QC Criteria

November 19, 2021

Last Verified

November 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on COVID-19 Pandemic

Clinical Trials on Questionnaire

Subscribe